Video Experimental Relacionado
Updated: Jun 20, 2026

11:31
Using Micro-computed Tomography for the Assessment of Tumor Development and Follow-up of Response to Treatment in a Mouse Model of Lung Cancer
Published on: May 20, 2016
10.8K
Reflexiones del autor: ¿Es suficiente la evaluación de la respuesta PET/CT después de la terapia sistémica
Ronen Stoff1, Matthew S Block2, Tina J Hieken3
1Department of Oncology, Mayo Clinic, Rochester, MN, USA. Stoff.ronen@mayo.edu.
Annals of surgical oncology
|August 29, 2025
Resumen
No abstract available in PubMed .
Videos de Conceptos Relacionados
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

